Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:07:17.325Z.
Calculation as of: 2026-10-06T18:07:17.325Z.
Quote observation: 2026-10-06T18:05:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: df0d51bc4c7c4fe031789de0e9442acf829cec50a05ec95901a80cda74a8a9f3
EARNINGS YIELD
N/A
Market Cap
$3.03B
Earnings Yield
0.86%
TTM Avg
0.82%
3Y Avg
0.82%
5Y Avg
0.82%
Market Cap
$3.08B
Earnings Yield
N/A
TTM Avg
25.02%
3Y Avg
25.02%
5Y Avg
25.02%
Market Cap
$3.10B
Earnings Yield
N/A
TTM Avg
0.44%
3Y Avg
0.44%
5Y Avg
0.44%
Market Cap
$2.80B
Earnings Yield
4.77%
TTM Avg
3.82%
3Y Avg
2.33%
5Y Avg
2.33%
Market Cap
$3.19B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | $2.99B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.03B | 0.86% | 0.82% | 0.82% | 0.82% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.08B | N/A | 25.02% | 25.02% | 25.02% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.10B | N/A | 0.44% | 0.44% | 0.44% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 4.77% | 3.82% | 2.33% | 2.33% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 0.39% | 0.43% | 0.43% | 1.84% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | N/A | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.71B | N/A | 7.93% | 7.93% | 7.93% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | N/A | 8.33% | 6.72% | 5.70% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
